Deliver Your News to the World

Bayer CropScience Expands Cooperation with Brazilian Wheat-Breeding Company Biotrigo


Monheim, – Bayer CropScience and the Brazilian wheat-breeding company Biotrigo Genetica Ltda. have signed an agreement to expand their successful cooperation. With this agreement, Bayer will be able to use the lineage of new wheat varieties of one of Brazil’s leading wheat breeding companies. Biotrigo’s germplasm pool is renowned for its yield, high milling and baking quality and disease resistance. Financial details were not disclosed.

“Our agreement with Biotrigo is another step towards a world-class research platform for wheat genetics,” said Hartmut van Lengerich, Head of Cereals and Fungicides at Bayer CropScience. “We have entered into collaborations with the best partners in wheat research and breeding across the world. Now we are also looking forward to working with the motivated and experienced Biotrigo team.”

“Biotrigo is a global leader in combining grain yield and end-use quality with resistance to difficult-to-control diseases,” said Edward Souza, Director of Wheat Breeding at Bayer CropScience. “Their guidance will help us continue to build our capacity in Europe and emerging markets.”

For André Rosa, Biotrigo Business Director, the agreement with Bayer CropScience is important because it strengthens the company’s growth and contributes to its vision of leadership in Latin America.

According to Ottoni Rosa Filho, Biotrigo Technical Director, the agreement will enable an even greater investment in research and development, contributing to generations of innovation for wheat farmers. "This agreement enables Biotrigo and its partners to be more competitive by enhancing their portfolio of cultivars in the medium and long-term,” assured Ottoni Rosa Filho.

According to André Rosa, Bayer CropScience is synonymous with quality in everything it does. “This agreement with one of the most successful and respected agricultural companies in the world thanks to its brand and solutions shows that the quality of research at Biotrigo is being recognized.”

Biotrigo is based in Passo Fundo in the region Rio Grande do Sul in southern Brazil. Both companies are already involved in a successful cooperation for the joint development of customized solutions consisting of wheat seeds and crop protection products for the Brazilian market. The expansion of this collaboration is focused on regions outside the Americas.

About Bayer CropScience
Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials. This year the company looks back on 150 years of working to fulfill its mission “Bayer: Science For A Better Life”. Bayer CropScience, the subgroup of Bayer AG responsible for the agricultural business, has annual sales of EUR 8,383 million (2012) and is one of the world’s leading innovative crop science companies in the areas of seeds, crop protection and non-agricultural pest control. The company offers an outstanding range of products including high value seeds, innovative crop protection solutions based on chemical and biological modes of action as well as an extensive service backup for modern, sustainable agriculture. In the area of non-agricultural applications, Bayer CropScience has a broad portfolio of products and services to control pests from home and garden to forestry applications. The company has a global workforce of 20,800 and is represented in more than 120 countries. This and further news is available at:

About Biotrigo
Biotrigo is a Brazilian wheat breeding company, located in Passo Fundo, Rio Grande do Sul, with a focus on development of wheat cultivars for Brazil and other Latin American countries. The company has three breeding programs, which have been delivering superior seeds to the wheat market over the years. The cultivars developed by Biotrigo are a result of more than 20 years of research. Its seeds are recognized as of high yield associated with breadmaking quality and resistance to diseases. Find more information at:

Find more information at

Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.


This news content was configured by WebWire editorial staff. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.